PLAU and neoplasm: Specifically, oncogenic KRAS upregulates uPA and uPA receptor (uPAR) expression in PDAC tumor cells, and uPA and uPAR expression in PDAC is strongly correlated with poor patient prognosis [17, 18, 19].